173 related articles for article (PubMed ID: 33528911)
1. Open-label study with the monoamine stabilizer (-)-OSU6162 in myalgic encephalomyelitis/chronic fatigue syndrome.
Haghighi S; Forsmark S; Zachrisson O; Carlsson A; Nilsson MKL; Carlsson ML; Schuit RC; Gottfries CG
Brain Behav; 2021 Apr; 11(4):e02040. PubMed ID: 33528911
[TBL] [Abstract][Full Text] [Related]
2. Open study with (-)-OSU6162 in multiple sclerosis-related fatigue.
Haghighi S; Forsmark S; Carlsson A; Nilsson MKL; Carlsson ML; Schuit RC; Gottfries CG
Acta Neurol Scand; 2018 Dec; 138(6):482-489. PubMed ID: 30132786
[TBL] [Abstract][Full Text] [Related]
3. A randomised controlled trial of the monoaminergic stabiliser (-)-OSU6162 in treatment of myalgic encephalomyelitis/chronic fatigue syndrome.
Nilsson MKL; Zachrisson O; Gottfries CG; Matousek M; Peilot B; Forsmark S; Schuit RC; Carlsson ML; Kloberg A; Carlsson A
Acta Neuropsychiatr; 2018 Jun; 30(3):148-157. PubMed ID: 29212562
[TBL] [Abstract][Full Text] [Related]
4. Tolerability and efficacy of the monoaminergic stabilizer (-)-OSU6162 (PNU-96391A) in Huntington's disease: a double-blind cross-over study.
Kloberg A; Constantinescu R; Nilsson MK; Carlsson ML; Carlsson A; Wahlström J; Haghighi S
Acta Neuropsychiatr; 2014 Oct; 26(5):298-306. PubMed ID: 25241758
[TBL] [Abstract][Full Text] [Related]
5. Oxaloacetate Treatment For Mental And Physical Fatigue In Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Long-COVID fatigue patients: a non-randomized controlled clinical trial.
Cash A; Kaufman DL
J Transl Med; 2022 Jun; 20(1):295. PubMed ID: 35764955
[TBL] [Abstract][Full Text] [Related]
6. Effect of Dietary Coenzyme Q10 Plus NADH Supplementation on Fatigue Perception and Health-Related Quality of Life in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial.
Castro-Marrero J; Segundo MJ; Lacasa M; Martinez-Martinez A; Sentañes RS; Alegre-Martin J
Nutrients; 2021 Jul; 13(8):. PubMed ID: 34444817
[TBL] [Abstract][Full Text] [Related]
7. Effect of the monoaminergic stabiliser (-)-OSU6162 on mental fatigue following stroke or traumatic brain injury.
Nilsson MKL; Johansson B; Carlsson ML; Schuit RC; Rönnbäck L
Acta Neuropsychiatr; 2020 Dec; 32(6):303-312. PubMed ID: 32418546
[TBL] [Abstract][Full Text] [Related]
8. Anxiety and depression in chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): Examining the incidence of health anxiety in CFS/ME.
Daniels J; Brigden A; Kacorova A
Psychol Psychother; 2017 Sep; 90(3):502-509. PubMed ID: 28244209
[TBL] [Abstract][Full Text] [Related]
9. (-)-OSU6162 in the treatment of fatigue and other sequelae after aneurysmal subarachnoid hemorrhage: a double-blind, randomized, placebo-controlled study.
Western E; Nordenmark TH; Sorteberg W; Sorteberg A; Karic T; Sorteberg A
J Neurosurg; 2022 Jun; 136(6):1705-1715. PubMed ID: 34715650
[TBL] [Abstract][Full Text] [Related]
10. How do women with chronic fatigue syndrome/myalgic encephalomyelitis rate quality and coordination of healthcare services? A cross-sectional study.
Hansen AH; Lian OS
BMJ Open; 2016 Apr; 6(4):e010277. PubMed ID: 27044578
[TBL] [Abstract][Full Text] [Related]
11. B-Lymphocyte Depletion in Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
Fluge Ø; Rekeland IG; Lien K; Thürmer H; Borchgrevink PC; Schäfer C; Sørland K; Aßmus J; Ktoridou-Valen I; Herder I; Gotaas ME; Kvammen Ø; Baranowska KA; Bohnen LMLJ; Martinsen SS; Lonar AE; Solvang AH; Gya AES; Bruland O; Risa K; Alme K; Dahl O; Mella O
Ann Intern Med; 2019 May; 170(9):585-593. PubMed ID: 30934066
[TBL] [Abstract][Full Text] [Related]
12. Does Coenzyme Q10 Plus Selenium Supplementation Ameliorate Clinical Outcomes by Modulating Oxidative Stress and Inflammation in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome?
Castro-Marrero J; Domingo JC; Cordobilla B; Ferrer R; Giralt M; Sanmartín-Sentañes R; Alegre-Martín J
Antioxid Redox Signal; 2022 Apr; 36(10-12):729-739. PubMed ID: 35229657
[TBL] [Abstract][Full Text] [Related]
13. Psychometric properties of the PROMIS
Yang M; Keller S; Lin JS
Qual Life Res; 2019 Dec; 28(12):3375-3384. PubMed ID: 31506915
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and characteristics of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) in Poland: a cross-sectional study.
Słomko J; Newton JL; Kujawski S; Tafil-Klawe M; Klawe J; Staines D; Marshall-Gradisnik S; Zalewski P
BMJ Open; 2019 Mar; 9(3):e023955. PubMed ID: 30850404
[TBL] [Abstract][Full Text] [Related]
15. Pain is associated with reduced quality of life and functional status in patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
Strand EB; Mengshoel AM; Sandvik L; Helland IB; Abraham S; Nes LS
Scand J Pain; 2019 Jan; 19(1):61-72. PubMed ID: 30325738
[TBL] [Abstract][Full Text] [Related]
16. The Effects of (-)-OSU6162 on Chronic Fatigue in Patients With Traumatic Brain Injury: A Randomized Controlled Trial.
Berginström N; Nordström P; Schuit R; Nordström A
J Head Trauma Rehabil; 2017; 32(2):E46-E54. PubMed ID: 27120292
[TBL] [Abstract][Full Text] [Related]
17. Assessing severity of illness and outcomes of treatment in children with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME): a systematic review of patient-reported outcome measures (PROMs).
Haywood KL; Collin SM; Crawley E
Child Care Health Dev; 2014 Nov; 40(6):806-24. PubMed ID: 24661148
[TBL] [Abstract][Full Text] [Related]
18. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Induced by Repeated Forced Swimming in Mice.
Ohba T; Domoto S; Tanaka M; Nakamura S; Shimazawa M; Hara H
Biol Pharm Bull; 2019; 42(7):1140-1145. PubMed ID: 31257290
[TBL] [Abstract][Full Text] [Related]
19. Defining the prevalence and symptom burden of those with self-reported severe chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): a two-phase community pilot study in the North East of England.
Strassheim VJ; Sunnquist M; Jason LA; Newton JL
BMJ Open; 2018 Sep; 8(9):e020775. PubMed ID: 30232103
[TBL] [Abstract][Full Text] [Related]
20. The utility of patient-reported outcome measures among patients with myalgic encephalomyelitis/chronic fatigue syndrome.
Murdock KW; Wang XS; Shi Q; Cleeland CS; Fagundes CP; Vernon SD
Qual Life Res; 2017 Apr; 26(4):913-921. PubMed ID: 27600520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
